Wed, 28 Mar 2018 11:35:56 GMT
Japanese Takeda considers bod for London-listed Shire
The Japanese biggest drugmaker Takeda Pharmaceutical is weighting a bid for the London-listed drugmaker Shire to expand in hyperactivity drugs, rare diseases and the United States, bringing its shares up 25%.